Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

Aug 1, 2000

Dianolyn Capsules Recalled

First public notice issued by FDA of 'completed recall'...

Alhambra, CA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Diabetic Capital (U.S.) LLC is conducting a recall of Dianolyn Capsules because the product fails to declare prescription drug ingredient glyburide.

Dianolyn(tm) Capsules, OTC oral dietary supplement, in bottles of 30.

Recall #D-439-0.  Class I

Lot #0914 EXP 10/02.

Phyytos Nutri-Pharma, Corona, California. (contract manufacturer).

Diabetic Capital (U.S.) LLC, Alhambra, California (responsible firm), by telephone on March 16, 2000, by press release on March 22, 2000, and by letter on March 24, 2000. Firm-initiated recall complete.  This is the first public notice issued by the FDA.

California, Florida, Georgia, Kansas, Louisiana, Maryland, Missouri, Oregon, Pennsylvania, Texas, Virginia and the District of Columbia.

10,788 boxes were distributed.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafeMail subscribers August 1, 2000.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.